The drop represents a return to a more normal pace of openings post-pandemic but likely also reflects the reimbursement and regulatory challenges facing the industry.

Quest will become the exclusive independent national laboratory provider of clinical lab and anatomic pathology services for Sentara members in Florida and Virginia.

Last week, readers were most interested in a story about how diagnostic firms may be impacted by the FDA's final rule on laboratory-developed tests.

NEW YORK – Test makers that have taken the lead on bringing high-sensitivity cardiac troponin testing to the point of care have said that bringing testing into the emergency room can help doctors to ...

NEW YORK – Digital pathology firm PathPresenter said Thursday that it has raised $7.5 million in a Series A funding round. The round was led by Avant Bio with participation by Barco NV and Modi ...